Lumicell, an MIT spinout, has developed a handheld device with an optical imaging agent that enables surgeons to see real-time tissue images during surgery. This innovation helps detect residual cancer cells, allowing for more precise tissue removal and potentially reducing the need for follow-up surgeries. During clinical trials, the technology significantly decreased the need for second surgeries and identified tissue likely to contain cancer cells that standard lumpectomy procedures might have overlooked.
New device offers a real-time view of breast cancer during surgery
It eliminates the need for follow-up surgeries.
Explore more ..
Tesla’s Roadster Could Get SpaceX-Inspired Thrusters
Tesla has proposed rocket-related technology for its electric sports car, but it still needs to prove its capabilities.
AMD’s Venice CPUs Bring 256 Cores to Agentic AI
AMD’s 6th-gen EPYC 9006 processors pair Zen 6 and TSMC’s 2nm process to handle the growing CPU demands of agentic AI.
Samsung Unveils New Memory Tech for AI
Samsung showcases zHBM, zNAND-O and 400-layer V10 BV-NAND at FMS 2026.
Intel Collaborates with Lens Technology on Glass Chip Packaging
The partnership aims to speed up glass substrate manufacturing, a technology expected to power future AI chips, servers, robotics, and edge devices.


